Veterans Affairs Clinical Epidemiology Research Center, West Haven, CT 06250-8025, USA.
Am J Med. 2013 Jan;126(1):49-57. doi: 10.1016/j.amjmed.2012.07.016. Epub 2012 Nov 20.
Among older persons, within the clinical context of respiratory symptoms and mobility, evidence suggests that improvements are warranted regarding the current approach for identifying respiratory impairment (ie, a reduction in pulmonary function).
Among 3583 white participants aged 65 to 80 years (Cardiovascular Health Study), we calculated the prevalence of respiratory impairment using the current spirometric standard from the Global Initiative for Obstructive Lung Disease (GOLD) and an alternative spirometric approach termed "lambda-mu-sigma" (LMS). Results for GOLD- and LMS-defined respiratory impairment were evaluated for their (cross-sectional) association with respiratory symptoms and gait speed, and for the 5-year cumulative incidence probability of mobility disability.
The prevalence of respiratory impairment was 49.7% (1780/3583) when using the GOLD and 23.2% (831/3583) when using LMS. Differences in prevalence were most evident among participants who had no respiratory symptoms, with respiratory impairment classified more often by the GOLD (38.1% [326/855]) than LMS (12.3% [105/855]), as well as among participants who had normal gait speed, with respiratory impairment classified more often by the GOLD (46.4% [1003/2164]) than LMS (19.3% [417/2164]). Conversely, the 5-year cumulative incidence probability of mobility disability for respiratory impairment was higher for LMS than GOLD (0.313 and 0.249 for never-smokers, and 0.352 and 0.289 for ever-smokers, respectively), but was similar for normal spirometry by LMS or GOLD (0.193 and 0.185 for never-smokers, and 0.219 and 0.216 for ever-smokers, respectively).
Among older persons, the LMS approach (vs the GOLD approach) classifies respiratory impairment less frequently in those who are asymptomatic and is more strongly associated with mobility disability.
在老年人中,在呼吸系统症状和活动能力的临床背景下,有证据表明,有必要改进当前识别呼吸功能障碍(即肺功能下降)的方法。
在年龄在 65 至 80 岁的 3583 名白种人参与者(心血管健康研究)中,我们使用全球倡议对阻塞性肺病(GOLD)的现行肺量计标准和称为“lambda-mu-sigma”(LMS)的替代肺量计方法计算呼吸功能障碍的患病率。评估 GOLD 和 LMS 定义的呼吸功能障碍与呼吸症状和步态速度的(横断面)关联,并评估 5 年累积移动障碍发生率概率。
使用 GOLD 时,呼吸功能障碍的患病率为 49.7%(1780/3583),而使用 LMS 时为 23.2%(831/3583)。在没有呼吸系统症状的参与者中,患病率差异最为明显,GOLD 分类为呼吸功能障碍的比例(38.1%[326/855])明显高于 LMS(12.3%[105/855]),而在步态速度正常的参与者中,GOLD 分类为呼吸功能障碍的比例(46.4%[1003/2164])明显高于 LMS(19.3%[417/2164])。相反,LMS 比 GOLD 分类的呼吸功能障碍的 5 年累积移动障碍发生率更高(从不吸烟者为 0.313 和 0.249,吸烟者为 0.352 和 0.289),而 LMS 或 GOLD 分类的正常肺功能则相似(从不吸烟者为 0.193 和 0.185,吸烟者为 0.219 和 0.216)。
在老年人中,与 GOLD 方法(相比),LMS 方法(在无症状者中)较少分类为呼吸功能障碍,并且与移动障碍的相关性更强。